Population pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with type 2 diabetes-Reference-Cited by-同舟云学术

Population pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with type 2 diabetes

Published:2013-08-13 Issue:10 Volume:53 Page:1028-1038
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:J Clin Pharmacol

Author:

Riggs Matthew M.¹,Staab Alexander²,Seman Leo³,MacGregor Thomas R.³,Bergsma Timothy T.¹,Gastonguay Marc R.¹,Macha Sreeraj³

Affiliation:

1. Metrum Research Group LLC; Tariffville; CT; USA

2. Boehringer Ingelheim Pharma GmbH & Co. KG; Biberach; Germany

3. Boehringer Ingelheim Pharmaceuticals, Inc.; Ridgefield; CT; USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.147/fullpdf

Reference33 articles.

1. International Diabetes Federation Diabetes Atlas Fourth Edition. Prevalence estimates of diabetes mellitus (DM), 2010. International Diabetes Federation, 2010. Available at http://www.diabetesatlas.com/content/prevalence-estimates-diabetes-mellitus-dm-2010

2. Molecular understanding of hyperglycemia's adverse effects for diabetic complications;Sheetz;JAMA.,2002

3. Impact of diabetes on vasculature: focus on nervous system;Skljarevski;Curr Diabetes Rev.,2005

4. Cellular and molecular mechanisms of vascular injury in diabetes-part I: pathways of vascular disease in diabetes;Madonna;Vasc Pharmacol.,2011

5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet.,1998

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A potential novel treatment for cirrhosis‐related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease;British Journal of Clinical Pharmacology;2024-06-16

2. A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects;Pharmaceuticals;2024-04-18

3. Influence of Weight and Body Size on the Pharmacokinetics of Heart Failure Pharmacotherapy: A Systematic Review;Annals of Pharmacotherapy;2023-06-20

4. Algorithms and methodological challenges in the development and application of quantitative systems pharmacology models: a case study in type 2 diabetes;Russian Journal of Numerical Analysis and Mathematical Modelling;2022-11-01

5. Utilization of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacoepidemiological Studies: A Systematic Review on Antiarrhythmic and Glucose-Lowering Medicines;Frontiers in Pharmacology;2022-06-20